BGM0504

DRUG7 trials

Sponsors

BrightGene Bio-Medical Technology Co., Ltd.

Conditions

Non-diabetic Overweight or ObeseObesityOverweight or ObeseOverweight or ObesityType 2 Diabetes (T2DM)Type 2 Diabetes Mellitus (T2DM)

Phase 1

A Study of BGM0504 in Overweight or Obese Participants

CompletedNCT06920056

BrightGene Bio-Medical Technology Co., Ltd.Overweight or Obese

Start: 2025-03-24End: 2025-07-25Updated: 2025-09-09

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

CompletedNCT06929156

BrightGene Bio-Medical Technology Co., Ltd.Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)

Start: 2025-05-06End: 2025-12-25Updated: 2026-02-11

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

RecruitingNCT07166081

BrightGene Bio-Medical Technology Co., Ltd.Non-diabetic Overweight or Obese

Start: 2025-08-11End: 2026-05-13Target: 80Updated: 2025-09-19

Phase 2

A Study of BGM0504 in Participants With Obesity

RecruitingNCT06911203

BrightGene Bio-Medical Technology Co., Ltd.Obesity

Start: 2025-04-03End: 2026-01-11Target: 90Updated: 2025-10-28

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

CompletedNCT06973681

BrightGene Bio-Medical Technology Co., Ltd.Overweight or Obesity

Start: 2023-10-13End: 2024-09-13Updated: 2025-05-15

Phase 3

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

RecruitingNCT07064486

BrightGene Bio-Medical Technology Co., Ltd.Type 2 Diabetes (T2DM)

Start: 2025-07-04End: 2026-07-31Target: 477Updated: 2025-10-28

A Study of BGM0504 in Early T2DM With Obesity

RecruitingNCT07743983

BrightGene Bio-Medical Technology Co., Ltd.Type 2 Diabetes (T2DM)

Start: 2026-08-30End: 2028-11-30Target: 372Updated: 2026-08-04

Related Papers

Effectiveness, Safety and Pharmacokinetics of BGM0504 , a Dual GLP ‐1/ GIP Receptor Agonist, in Chinese Adults With Overweight or Obesity Without Diabetes: A Phase 2 Multicentre, Randomized, Double‐Blind, Placebo‐Controlled Trial

Diabetes Obesity and Metabolism2026-09-17